MaxCyte (NasdaqGS:MXCT) Q4 2025 Earnings call March 24, 2026 04:30 PM ET Company ParticipantsDouglas Swirsky - CFOErik Abdo - Director of Investor RelationsMaher Masoud - President and CEOSean Menarguez - Senior Director of Business DevelopmentVidyun Bais - VP in Equity ResearchConference Call ParticipantsChad Wiatrowski - AnalystDan Arias - Managing Director & Senior Equity Research AnalystJacob Johnson - AnalystMatt Etoch - Research AnalystMatt Hewitt - Senior Research AnalystOperatorPlease note, this con ...

MaxCyte (NasdaqGS:MXCT) Q4 2025 Earnings call March 24, 2026 04:30 PM ET Company ParticipantsDouglas Swirsky - CFOErik Abdo - Director of Investor RelationsMaher Masoud - President and CEOSean Menarguez - Senior Director of Business DevelopmentVidyun Bais - VP in Equity ResearchConference Call ParticipantsChad Wiatrowski - AnalystDan Arias - Managing Director & Senior Equity Research AnalystJacob Johnson - AnalystMatt Etoch - Research AnalystMatt Hewitt - Senior Research AnalystOperatorPlease note, this con ...

MaxCyte (NasdaqGS:MXCT) Q4 2025 Earnings call March 24, 2026 04:30 PM ET Speaker8Please note, this conference is being recorded. Now we'll turn the call over to Erik Abdo with Investor Relations. Please proceed.Speaker3Good afternoon, everyone. Thank you for participating in today's conference call. Joining me on the call from MaxCyte, we have Maher Masoud, President and Chief Executive Officer, Douglas Swirsky, Chief Financial Officer, and Sean Menarguez, Senior Director of Business Development. Earlier to ...